MMRGlobal Invites Shareholders to Sneak Peek "Eat on Us" Campaign and to Participate in Investor Call

LOS ANGELES, CA--(Marketwire - Aug 11, 2011) - MMRGlobal, Inc. (OTCBB: MMRF) (www.mymedicalrecords.com), a leading provider of Personal Health Records, MyEsafeDepositBox storage solutions and electronic document management systems for healthcare professionals, today announced a sneak peek at its "Eat on Us" direct-to-consumer campaign at http://phr.mmrcontent.com/sneakpeek/. The Company also announced it plans to hold an investor conference call to discuss its second quarter earnings for the period ended June 30, 2011, on Monday, August 15, 2011 at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time.

Robert H. Lorsch, Chief Executive Officer, Richard M. Lagani, Executive Vice President, and Ingrid Safranek, Chief Financial Officer, will review second quarter results and discuss the Company's outlook for the third and fourth quarters.

Management will also discuss its plans to launch its September "Eat on Us" campaign on Facebook, Twitter and a variety of additional social media and incentive marketing sites as well as update shareholders on sales of MMRPro and plans to offer MMRPatientView http://pv.mmrcontent.com/PatientViewFlipBook/ to physicians nationwide. Additionally, the Company will discuss planned integrations with prospects and other strategic partners including 4medica, Alcatel-Lucent, Chartis, HealthVault®, Interbit Data, and internationally in China and Australia.

Following the presentation, management will answer questions from stockholders.

The Company plans on filing its Form 10-Q with the Securities and Exchange Commission as well as issue a second quarter earnings release after the close of market on August 15 in advance of the call. The conference call will be broadcast live over the Internet at http://phx.corporate-ir.net/phoenix.zhtml?p=irol-eventDetails&c=178404&eventID=4175454 or by linking to Investor Relations at www.mmrglobal.com. Participants should register 15 minutes prior to the start of the conference to download any required video software. The call may also be accessed by dialing (800) 920-8624 (inside the U.S) or (617) 597-5430 (International), using Passcode 87816819.

A replay of the webcast will be available on the MMRGlobal Investor Relations website and by telephone approximately two hours after the live broadcast ends. The telephonic replay will also be available at (888) 286-8010 (U.S.) or (617) 801-6888 (International), using conference ID #51460264.

For any questions, please contact info@mmrmail.com.

About MMRGlobal, Inc.

MMRGlobal, Inc., through its wholly-owned operating subsidiary, MyMedicalRecords, Inc. ("MMR") (www.mymedicalrecords.com), provides secure and easy-to-use online Personal Health Records ("PHRs") and electronic safe deposit box storage solutions, serving consumers, healthcare professionals, employers, insurance companies, financial institutions, and professional organizations and affinity groups. MyMedicalRecords enables individuals and families to access their medical records and other important documents, such as birth certificates, passports, insurance policies and wills, anytime from anywhere using the Internet. The MyMedicalRecords Personal Health Record is built on proprietary, patented technologies to allow documents, images and voicemail messages to be transmitted and stored in the system using a variety of methods, including fax, phone, or file upload without relying on any specific electronic medical record platform to populate a user's account. The Company's professional offering, MMRPro, is designed to give physicians' offices an easy and cost-effective solution to digitizing paper-based medical records and sharing them with patients in real time through an integrated patient portal. MMR is an Independent Software Vendor Partner with Kodak to deliver an integrated turnkey EMR solution for healthcare professionals. Through its merger with Favrille, Inc. in January 2009, the Company acquired intellectual property biotech assets that include anti-CD20 antibodies and data and samples from its FavId™/Specifid™ vaccine clinical trials for the treatment of B-Cell Non-Hodgkin's lymphoma. To learn more about MMRGlobal, Inc. and its products, visit www.mmrglobal.com.

Forward-Looking Statements

Statements in this press release that are not strictly historical in nature, including future performance, management's expectations, beliefs, intentions, estimates or projections, constitute "forward-looking statements." Such forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause the Company's actual results to be materially different from historical results or from any results expressed or implied by such forward-looking statements. Some can be identified by the use of words (and their derivations) such as "need," "possibility," "offer," "development," "if," "negotiate," "when," "begun," "believe," "achieve," "will," "estimate," "expect," "maintain," "plan," and "continue," or the negative of these words. Factors that could cause or contribute to such differences include, but are not limited to, the risk the Company's products are not adopted or viewed favorably by the healthcare community and by consumers; risks related to the current uncertainty and instability in financial and lending markets, including global economic uncertainties; variations in our quarterly operating results; scheduling of planned events; product integration in physician practices and hospitals; timing and volume of sales and installations; length of sales cycles and the installation process; market acceptance of new product introductions; ability to establish and maintain strategic relationships; ability to identify and integrate acquisitions; relationships with licensees; competitive product offerings and promotions; changes in government laws and regulations and future changes in tax legislation and initiatives in the healthcare industry; undetected errors in our products; possibility of interruption at our data centers; risks related to third party vendors; risks related to obtaining and integrating third-party licensed technology; acceptance of the Company's marketing and promotional campaigns; risks related to a security breach by third parties; maintaining, developing and defending our intellectual property rights including those pertaining to our biotechnology assets; risks associated with recruitment and retention of key personnel; uncertainties associated with doing business internationally across borders and territories; and additional risks discussed in the Company's filings with the Securities and Exchange Commission. Additionally, we are a developing early-stage company and many variables can affect revenues and/or projections, including factors out of our control. The Company is providing this information as of the date of this release and, except as required by law, does not undertake any obligation to update any forward-looking statements contained in this release as a result of new information, future events or otherwise.